Press Release: Oscar Health, Inc. 2024 Fourth Quarter and Full Year Earnings Conference Call

Dow Jones
09 Jan

Oscar Health, Inc. 2024 Fourth Quarter and Full Year Earnings Conference Call

NEW YORK--(BUSINESS WIRE)--January 09, 2025-- 

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2024 financial results after the market closes on Tuesday, February 4, 2025.

Management will review these results in a conference call beginning at 5:00 PM $(ET)$. The call-in number and webcast link are as follows:

Live Call: 1.855.761.5600

Conference ID: 7768132

Webcast

The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following February 4, 2025 for a period of 90 days.

About Oscar Health

Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. We have been challenging the status quo in the healthcare system since our founding in 2012, and are dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Our technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 1.65 million members, as of September 30, 2024.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250109337618/en/

 
    CONTACT:    Investor: 

Chris Potochar

VP of Investor Relations

ir@hioscar.com

Media:

Kristen Prestano

VP of Communications

press@hioscar.com

 
 

(END) Dow Jones Newswires

January 09, 2025 08:01 ET (13:01 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10